ETAHX
Price
$46.93
Change
+$0.36 (+0.77%)
Updated
Nov 18 closing price
Net Assets
1.57B
FSPHX
Price
$30.12
Change
-$0.01 (-0.03%)
Updated
Nov 18 closing price
Net Assets
6.22B
Interact to see
Advertisement

ETAHX vs FSPHX

Header iconETAHX vs FSPHX Comparison
Open Charts ETAHX vs FSPHXBanner chart's image
Eventide Healthcare & Life Sciences A
Price$46.93
Change+$0.36 (+0.77%)
VolumeN/A
Net Assets1.57B
Fidelity Select Health Care
Price$30.12
Change-$0.01 (-0.03%)
VolumeN/A
Net Assets6.22B
ETAHX vs FSPHX Comparison Chart in %
View a ticker or compare two or three
VS
ETAHX vs. FSPHX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETAHX is a Hold and FSPHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.22B vs. ETAHX (1.57B). FSPHX pays higher dividends than ETAHX: FSPHX (0.02) vs ETAHX (0.00). ETAHX was incepted earlier than FSPHX: ETAHX (13 years) vs FSPHX (44 years). ETAHX (1.57) is less costly to investors than FSPHX (0.63). ETAHX (41.00) and FSPHX (40.00) have comparable annual turnover. FSPHX has a lower initial minimum investment than ETAHX: FSPHX (0) vs ETAHX (1000). ETAHX annual gain was more profitable for investors over the last year : 43.25 vs. FSPHX (0.35). FSPHX (-8.45) and ETAHX (-8.71) have equivalent 5 years return.
ETAHXFSPHXETAHX / FSPHX
Total Expense Ratio1.570.63249%
Annual Report Gross Expense Ratio1.570.63249%
Fund Existence13 years44 years-
Gain YTD44.62710.569422%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.57B6.22B25%
Annual Yield % from dividends0.000.02-
Returns for 1 year43.250.3512,358%
Returns for 3 years54.7210.51521%
Returns for 5 years-8.71-8.45103%
Returns for 10 years97.7539.39248%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPMHX8.480.01
+0.12%
Invesco SteelPath MLP Alpha R5
PEMGX42.33N/A
N/A
Principal MidCap A
BRUFX564.44N/A
N/A
Bruce
REMVX11.11N/A
N/A
RBC Emerging Markets Value Equity I
CVTCX55.08-0.41
-0.74%
Calamos Growth & Income C